研究论文

1株红树来源真菌Penicillium janthinellum XLN32122次级代谢产物与生物活性研究

  • 石珏莹 a, b ,
  • 仇毅康 a, b ,
  • 兰晶 a, b ,
  • 徐振洋 a, b ,
  • 王熠 a, b ,
  • 李嘉祥 a, b ,
  • 罗由萍 a, b ,
  • 黄国雷 , a, b, * ,
  • 郑彩娟 , a, b, *
展开
  • a 海南师范大学 热带药用资源化学教育部重点实验室 海口 571158
  • b 海南师范大学化学与化工学院 热带药用植物化学海南省重点实验室 海口 571158

收稿日期: 2025-06-18

  修回日期: 2025-09-18

  网络出版日期: 2025-10-30

基金资助

国家自然科学基金(32160108)

海南省重点研发计划(ZDYF2024SHFZ116)

海南省院士创新平台专项(YSPTZX202309)

海南省高等学校科学研究项目(Hnky2022ZD-6)

海南师范大学大学生创新训练(202411658006)

Research on Secondary Metabolites from a Mangrove-Derived Fungus Penicillium janthinellum XLN32122 and Their Biological Activities

  • Jueying Shi a, b ,
  • Yikang Qiu a, b ,
  • Jing Lan a, b ,
  • Zhenyang Xu a, b ,
  • Yi Wang a, b ,
  • Jiaxiang Li a, b ,
  • Youping Luo a, b ,
  • Guolei Huang , a, b, * ,
  • Caijuan Zheng , a, b, *
Expand
  • a Key Laboratory of Tropical Medicinal Resources Chemistry of Ministry of Education, Hainan Normal University, Haikou 571158
  • b Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou 571158

Received date: 2025-06-18

  Revised date: 2025-09-18

  Online published: 2025-10-30

Supported by

National Natural Science Foundation of China(32160108)

Science and Technology Special Fund of Hainan Province(ZDYF2024SHFZ116)

Specific Research Fund of the Innovation Center for Academicians of Hainan Province(YSPTZX202309)

Scientific Research Project of Hainan Higher Education Institutions(Hnky2022ZD-6)

Hainan Normal University National College Student Innovation Training Program(202411658006)

摘要

对1株红树来源真菌Penicillium janthinellum XLN32122的次级代谢产物进行研究, 从中分离得到1个新的含有1,2-氧杂十二环的杂环二肽化合物trichodermamide H (1), 3个类似物以及3个已知的聚酮类化合物. 综合运用一维、二维核磁共振波谱、高分辨质谱和电子圆二色性(ECD)光谱确定了化合物1的平面结构和绝对构型. 体外抗炎活性结果显示, Trichodermamide B (3)对脂多糖(LPS)诱导的RAW 264.7细胞中NO的产生具有显著的抑制活性, IC50值为(13.13±0.005) μmol/L, 强于阳性对照药物地塞米松[IC50=(136.84±1.33) μmol/L]. 体外抗菌活性测试表明, 化合物3对耐甲氧西林金黄色葡萄球菌有一定的抑制活性(IC50=12.5 μg/mL), 阳性对照万古霉素的IC50值为1.56 μg/mL.

本文引用格式

石珏莹 , 仇毅康 , 兰晶 , 徐振洋 , 王熠 , 李嘉祥 , 罗由萍 , 黄国雷 , 郑彩娟 . 1株红树来源真菌Penicillium janthinellum XLN32122次级代谢产物与生物活性研究[J]. 有机化学, 2026 , 46(2) : 678 -683 . DOI: 10.6023/cjoc202506026

Abstract

A new heterocyclic dipeptide with a highly functionalized 1,2-oxazadecaline core, named trichodermamide H (1), and three known analogues, along with three known polyketides, were isolated from the fermentation extract of the mangrove- derived fungus Penicillium janthinellum XLN32122. The structure of 1 was elucidated on the basis of extensive 1D and 2D NMR spectra data analysis, HR-ESI-MS, electronic circular dichroism (ECD) calculations. Trichodermamide B (3) exhibited better inhibitory effect on nitric oxide (NO) production in lipopolysaccharide (LPS) induced RAW 264.7 cells with an IC50 value of (13.13±0.005) μmol/L than that of the positive control dexamethasone [IC50=(136.84±1.33) μmol/L]. Compound 3 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) with an IC50 value of 12.5 μg/mL, while the positive control vancomycin showed an IC50 value of 1.563 μg/mL.

1 Introduction

The Penicillium genus has the potential to produce a large quantity of secondary metabolites with appealing bioactivities, such as cytotoxic,[1] antimicrobial[2] and antileukemia[3] activities. Penicillin, a well-known broad-spectrum antibiotic, was isolated from the genus Penicillium, inspiring researchers to investigate other potent natural products from this genus of fungi. Among them, P. janthinellum is a potential producer of secondary metabolites whose natural products have been noticed due to their various chemical structures and biological activities.[4] It has a wide distribution in terrestrial environments, such as ginseng plants in China,[5] the fruits of Melia azedarach in Brazil,[6] gold mine tailings in South Africa[7] and the soils of the Truelove Lowland in Canada,[8] as well as many marine areas, such as the Bohai Sea,[9] South China Sea[10] and Amursky Bay,[11] which may be attributed to its capacity to generate numerous secondary metabolites. Structurally diverse secondary metabolites have been found in the fungi of P. janthinellum, including polyketides, alkaloids and terpenoids, which displayed attractive biological activities, such as cytotoxic, antibacterial, antifungal and antiviral activities. Novel acorane-type sesquiterpene penijanacorane C, isolated and characterized from the deep-sea-derived fungus P. janthinellum SH0301, exhibited significant inhibitory activity against lipopolysaccharide (LPS) induced NO production in RAW264.7 macrophages with an IC50 value of 6.23 μmol/L, which was more potent than that of positive control dexamethasone (IC50=11.49 μmol/L)[12]. Brefeldin A was isolated from the fungus P. janthinellum, and showed significant cytotoxicity against HL-60, U87MG, MDA-MB- 231, A549, HEP-3B, SW480 and NCM460 with IC50 values from (0.01±0.00) to (0.11±0.02) μmol/L.[13] Three new epipolythiodioxopiperazine alkaloids, penicisulfuranols A~C, were isolated from the mangrove endophytic fungus P. janthinellum HDN13-309, and showed cytotoxicity with IC50 values ranging from 0.1 to 3.9 μmol/L.[14] These results indicate that P. janthinellum is a potential fungus for producing bioactive secondary metabolites which can be used as precursors for new drugs.[15-21]
Mangroves grow in tropical and subtropical intertidal areas that feature high salinity, low oxygen content, strong UV radiation, and frequent tidal changes. These unique ecological conditions allow the microorganisms in mangroves to produce metabolites possessing distinctive chemical structures and bioactivities. Among them, the fungus genus Penicillium sp. is a significant source of pharmaceutical lead compounds. During our ongoing investigations of the fungi inhabiting mangrove environments,[22-27] the fermentation of the fungus P. janthinellum XLN32122, isolated from the mangrove Acanthus ebracteatus Vahl, displayed significant anti-inflammatory activity, with an IC50 value of (3.67±0.154) μg/mL. The subsequent purification has led to the discovery of seven compounds, including a new heterocyclic dipeptide tricho- dermamide H (1), and six known compounds trichodermamides A (2), B (3),[28] trichodermamide D (4),[29] 7-hydroxy-2-hydroxymethyl-5-methyl-4H-chromen-4-one (5),[30] 7-hydroxy-2-(2-hydroxypropyl)-5-methylchromone (6),[31] and striatisporolide A (7)[32] (Figure 1). Herein, we report the isolation, structure elucidation, and the bioactivity of these compounds.
Figure 1 Chemical structures of compounds 1~7

2 Results and discussion

2.1 Structure elucidation

Trichodermamide H (1) was isolated as a yellow amorphous powder. The molecular formula of compound 1 was established as C20H20N2O9 based on HR-ESI-MS [M+ Na] ion peak (calcd for C20H20N2O9Na 455.1066, found 455.1056), indicating 12 degrees of unsaturation. The 1H NMR data (Table 1), combined with the heteronuclear multiple quantum coherence (HMQC) spectrum of 1 in DMSO-d6, showed an exchangeable hydrogen signal at δH 9.32 (s, 1H, NH), three hydroxyl groups at δH 5.46 (d, J=6.4 Hz,1H, 8-OH), 5.31 (d, J=4.8 Hz, 1H, 5-OH), and 5.09 (s, 1H, 4-OH), two aromatic protons at δH 7.49 (d, J=8.8 Hz, 1H, H-5') and 7.13 (d, J=8.8 Hz, 1H, H-6'), three olefinic protons at 5.69 (ddd, J=10.4, 4.8, 2.4 Hz, 1H, H-6) and 5.48 (dd, J=10.4, 2.4 Hz, 1H, H-7), three methine groups at δH 3.82 (br d, J=4.8 Hz, 1H, H-5), 3.97 (t, J=7.6 Hz, 1H, H-8) and 4.11 (dd, J=7.6, 2.0 Hz, 1H, H-9), two methoxy groups at δH 3.89 (1H, s, H-10') and 3.83 (1H, s, H-11'), and one methylene group at δH 2.07 (d, J=18.8 Hz, 1H, H-3α) and 2.28 (dd, J=18.8, 2.4 Hz, 1H, H-3β). The 13C NMR data (Table 1), combined with distortionless enhancement by polarization transfer (DEPT)-135 spectrum of 1, showed the presence of two carbonyl carbons at δC 160.9 (C-1) and 157.9 (C-1'), 11 aromatic and olefinic sp2-carbons at δC 149.9 (C-2), 127.4 (C-6), 130.5 (C-7), 121.0 (C-2'), 123.9 (C-3'), 1113.7 (C-4'), 123.1 (C-5'), 110.2 (C-6'), 53.9 (C-7'), 135.3 (C-8') and 143.6 (C-9'), three oxygenated methine groups at δC 69.4 (C-5), 66.4 (C-8) and 63.9 (C-4), two methoxy carbons at δC 56.5 (C-10') and 60.9 (C-11'), one oxygenated quaternary sp3-carbon at δC 81.7 (C-9), and one methylene carbon at δC 26.3 (C-3). The 1H NMR and 13C NMR data of compound 1 were similar to those of trichodermamide A (2),[28] and had the same molecular formula as 2 on the basis of the HR-ESI-MS data. The major differences were the chemical shifts of C-5 at δH 3.82 (br d, J=4.8 Hz, 1H) and δC 69.4 (CH) in 1, instead of at δH 4.24 (br d, J=2.4 Hz, 1H) and δC 73.0 (CH) in 2, and the chemical shifts of C-9 at δH 4.11 (dd, J=7.6, 2.0 Hz, 1H) and δC 81.7 (CH) in 1, in contract to the chemical shifts at δH 3.99 (br s, 1H) and δC 83.8 (CH) in 2. The above results indicated that compounds 1 and 2 had the same plane structure, but differ in their configurations at the cyclohexane ring. The relative configuration of 1 was determined on the basis of nuclear overhauser effect spectroscopy (NOESY) and coupling constants. The NOESY correlations of H-5 to H-8 indicated that H-5 and H-8 were on the same side of the cyclohexane ring, and the correlations of 4-OH to 5-OH/8-OH, and 5-OH to 8-OH suggested that 4-OH, 5-OH and 8-OH oriented to the other side of the cyclohexane ring (Figure 2). In addition, the large coupling constants between H-8 (7.6 Hz) and H-9 (7.6, 2.0 Hz), consistent with literature data,[14,28] further confirmed their trans-diaxial orientation. The absolute configuration of 1 was determined on quantum chemical electronic circular dichroism (ECD) calculations. The theoretical ECD spectra of two possible stereoisomers of 4S,5S,8R,9S and 4R,5R,8S,9R were created by the time-dependent density functional theory (TDDFT) calculations, and the calculated ECD spectrum of the isomer 4S,5S,8R,9S matched well with the experimental ECD curve of 1 (Figure 3). Thus the structure of 1 was determined, and named as trichodermamide H (1).
Table 1 1H (400 MHz) and 13C (100 MHz) NMR data of compound 1 in DMSO-d6
Position δC δH (J in Hz)
1 160.9 (C)
2 149.9 (C)
3 26.3 (CH2) 2.07 (d, 18.8), 2.28
(dd, 18.8, 2.4)
4 63.9 (C)
4-OH 5.09 (s)
5 69.4 (CH) 3.82 (br d, 4.8)
5-OH 5.31 (d, 4.8)
6 127.4 (CH) 5.69 (ddd, 10.4, 4.8, 2.4)
7 130.5 (CH) 5.48 (dd, 10.4, 2.4)
8 66.4 (CH) 3.97 (t, 7.6)
8-OH 5.46 (d, 6.4)
9 81.7 (CH) 4.11 (dd, 7.6, 2.0)
1' 157.9 (C)
2' 121.0 (C)
3' 123.9 (CH) 8.53 (s)
4' 113.7 (C)
5' 123.1 (CH) 7.49 (d, 8.8)
6' 110.2 (CH) 7.13 (d, 8.8)
7' 153.9 (C)
8' 135.3 (C)
9' 143.6 (C)
10' 56.5 (OMe) 3.89 (s)
11' 60.9 (OMe) 3.83 (s)
NH 9.32 (s)
Figure 2 Key 1H- 1H COSY (), HMBC () and NOESY () correlations of compound 1
Figure 3 Experimental and calculated ECD spectra of compound 1

2.2 Biological activity

Compounds 1~7 were evaluated for their inhibitory activities against LPS-induced nitric oxide (NO) production in RAW 264.7 mouse macrophages, and dexamethasone was used as a positive control. Compounds 1~2 and 4~7 exhibited less than 50% inhibition at a concentration of 100 μmol/L. Only compound 3 demonstrated potent inhibition of NO accumulation induced by LPS on RAW 264.7 with the IC50 value of (13.13±0.005) μmol/L, which was stron- ger than the positive control dexamethasone [IC50=(136.84±1.33) μmol/L]. Furthermore, published studies have demonstrated that compound 3 exhibited potent antiproliferative activity against HCT-116 human colorectal carcinoma cell lines (IC50=0.32 μg/mL), HeLa cell lines [IC50=(3.1±0.5) μmol/L], and multiple human cancer cell lines.[28,33-34]
Compounds 1~7 were evaluated for their antibacterial activity against MRSA, while vancomycin was used as the positive control. Among them, only compound 3 displayed inhibitory activity against MRSA with an IC50 value of 12.5 μg/mL, while the positive control vancomycin showed an IC50 value of 1.563 μg/mL. These results indicate that chlo- rine atoms may play a crucial role in the bioactivity of these compounds.

3 Conclusions

In summary, a new heterocyclic alkaloid, and six known compounds were obtained from cultures of P. janthinellum XLN32122. Their structures were determined by extensive spectroscopic analyses and ECD calculations. Compound 3 demonstrated potent anti-inflammatory effects with an IC50 value of (13.13±0.005) μmol/L, and showed antibacterial activity against MRSA with the IC50 value of 12.5 μg/mL. This study provides a theoretical basis for the medicinal research on mangrove-derived Penicillium fungi and holds significant reference significance and value.

4 Experimental section

4.1 General experimental procedures

Modular Circular Polarimeter 500 (Anton Paar, Austria) polarimeter was used to detect optical rotation. JASCO J-715 spectrophotometer (JASCO, Japan) was used to measure ECD spectra. The 1D (1H and 13C) and 2D (HSQC, HMBC, COSY and NOESY) NMR spectra were measured on an NMR spectrometer (JEOL, 600 MHz, Japan) and a Bruker AV-400 (Bruker Corporation, Switzerland) instrument with TMS as the internal standard. Chemical shifts (δ) were referenced using the residual solvent signals of DMSO-d6 (δH 2.50, δC 39.5), CD3OD-d4 (δH 3.31, δC 49.0), and CDCl3 (δH 7.26, δC 77.2). ESI-MS and HR-ESI-MS spectra were obtained on a Bruker Daltonics Apex-Ultra 7.0 T (Bruker Corporation, Billerica, MA, USA) and a Q-TOF Ultima Global GAA076 LC mass spectrometer. For semipreparative HPLC, an Agilent 1100 prep-HPLC system with a Waters C18 semipreparative column (9.4 mm×250 mm, 7 μm) was used. Sephadex LH-20 (Pharmacia Co. Ltd., Sandwich, UK) and silica gel (200~300 and 300~400 mesh, Qingdao Marine Chemical Factory, Qingdao, China) were used for column chromatography (CC). Silica gel (GF254) for TLC was supplied by the Qingdao Marine Chemical Factory in China. All solvents used were of analytical grade (Guangzhou, China).

4.2 Fungal material

The fungal strain XLN32122 was isolated from the mangrove A. ebracteatus Vahl, collected in the Bamen Bay Mangrove Nature Reserve, Wenchang, Hainan Province, China in December 2022. It was stored in the Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, China. The strain was designated Penicillium janthinellum XLN32122 was based on BLAST analysis of the ITS sequence. Finally, the sequence was deposited in GenBank with the accession number PV688663.

4.3 Extraction and isolation

The fungal strain XLN32122 was grown on solid rice cultures in 1 L Erlenmeyer flasks (50 flasks; 50 mL of rice and 50 mL of water, and 0.5 g of sea salt per Erlenmeyer flask, autoclave sterilization) at 28 ℃ for 30 d. The fermentation was extracted three times with ethyl acetate (EtOAc, 25 L×3), and the combined extracts were concentrated under reduced pressure to afford a 30.0 g EtOAc extract.
The crude extract (30.0 g) was separated in ten fractions (Fr.1~Fr.10) by silica gel column chromatography (CC) eluting with a petroleum ether (PE)/EtOAc gradient system from 0∶1 to 1∶0. Fr.6 (2.5 g) was subjected to CC over octadecylsilyl (ODS) eluting with a MeOH/H2O gradient (10%~100%) to yield eight subfractions (Fr.6-1~ Fr.6-8). Fr.6-6 was purified by semipreparative HPLC (MeOH/H2O, VV=55∶45, 2 mL/min) to give compounds 1 (3.0 mg), 2 (2.5 mg), and 4 (3.6 mg). Fr.6-2 was purified by semipreparative HPLC (MeOH/H2O, VV=20∶80, 2 mL/ min) to give 3 (2.0 mg). Fr.4 (2.0 g) was subjected to CC over ODS eluting with a MeOH/H2O gradient (10%~100%) to yield eight subfractions (Fr.4-1~Fr.4-8). Fr.4-1 was purified by semipreparative HPLC (MeOH/H2O, VV=20∶80, 2 mL/min) to give compound 5 (3.5 mg). Fr.4-3 was purified by semipreparative HPLC (MeOH/H2O, VV=45∶55, 2 mL/min) to give compounds 6 (3.5 mg) and 7 (4.2 mg).
Trichodermamide H (1): Yellow amorphous powder. m.p. 158.3~159.6 ℃; $[a]_{\mathrm{D}}^{25}$+23.3 (c 0.5, CH3OH); UV (MeOH) λmax [log ε/(L•mol-1•cm-1)]: 251, 342 nm; IR (KBr) νmax: 3430, 1628, 1386, 1086, 475 cm-1; ECD (2.98 mmol/L, MeOH) λmax [∆ε/(L•mol-1•cm-1)]: 212 (-8.45), 250 (+12.95), 305 (+1.63), 354 (+2.73) nm; 1H and 13C NMR data see Table 1; HR-ESI-MS calcd for C20H20N2- O9Na [M+Na] 455.1066, found 455.1056.
Trichodermamide A (2): White needles. m.p. 224.0~226.0 ℃ (lit.[28] 224.0~226.0 ℃); 1H NMR (600 MHz, DMSO-d6) δ: 9.33 (s, 1H, NH), 8.55 (s, 1H, H-3'), 7.52 (d, J = 9.0 Hz, 1H, H-5'), 7.14 (d, J = 9.0 Hz, 1H, H-6'), 5.44~5.46 (m, 1H, H-6), 5.38~5.41 (m, 1H, H-7), 5.39~5.44 (overlapped, 1H, 8-OH), 5.46~5.55 (overlapped, 2H, 4-OH, 5-OH), 4.24 (br d, J = 2.4, 1H, H-5), 3.99 (br s, 2H, H-8, H-9), 3.90 (s, 3H, 10'-OMe), 3.84 (s, 3H, 11'-OMe), 2.47 (br s, 1H, H-3a), 2.03 (d, J = 19.2 Hz, 1H, H-3b); 13C NMR (150 MHz, DMSO-d6) δ: 161.1 (C-1), 157.9 (C-1'), 153.8 (C-7'),150.2 (C-2), 143.6 (C-9'), 135.3 (C-8′), 130.0 (C-6), 128.0 (C-7), 123.7 (C-3'), 123.1 (C-5'), 121.0 (C-2'), 113.7 (C-4'), 110.1 (C-6'), 84.0 (C-9), 73.2 (C-5), 67.4 (C-4), 66.2 (C-8), 60.9 (C-11'), 56.4 (C-10'), 23.2 (C-3); HR-ESI-MS calcd for C20H20N2O9Na [M+Na] 455.1061, found 455.1052.
Trichodermamide B (3):[28] Colorless oil. 1H NMR (400 MHz, MeOD) δ: 8.62 (s, 1H, H-3'), 7.33 (d, J = 8.8 Hz, 1H, H-5'), 7.10 (d, J = 8.8 Hz, 1H, H-6'), 5.60~5.73 (m, 2H, H-6, H-7), 4.90 (overlapped, 1H, H-5), 4.17~4.24 (overlapped, 2H, H-8, H-9), 3.95 (s, 3H, 10'-OMe), 3.93 (s, 3H, 11'-OMe), 2.83 (dd, J = 2.2, 19.4 Hz, 1H, H-3a), 2.32 (d, J = 19.4 Hz, 1H, H-3b); 13C NMR (100 MHz, MeOD) δ: 162.5 (C-1), 159.8 (C-1'),155.8 (C-7'), 151.1 (C-2), 145.4 (C-9'), 137.3 (C-8'), 130.4 (C-6), 128.9 (C-7),125.6 (C-3'), 124.0 (C-5'), 122.4 (C-2'), 115.4 (C-4'), 111.1 (C-6'), 85.5 (C-9), 68.9 (C-4), 67.6 (C-5), 66.4 (C-8), 61.8 (C-11'), 57.0 (C-10'), 25.8 (C-3); HR-ESI-MS calcd for C20H19ClN2O8Na [M+Na] 473.0723, found 473.0720.
Trichodermamide D (4):[29] Pale yellow powder. m.p. 209.3~210.7 ℃; 1H NMR (600 MHz, DMSO-d6) δ: 9.33 (s, 1H, NH), 8.53 (s, 1H, H-3'), 7.50 (d, J = 9.0 Hz, 1H, H-5'), 7.14 (d, J = 9.0 Hz, 1H, H-6'), 5.81 (d, J = 10.2 Hz, 1H, H-5), 5.69 (dd, J = 10.2, 4.8 Hz, 1H, H-6), 5.17~5.48 (overlapped, 1H, 4-OH), 4.24 (dd, J = 10.8, 1.8 Hz, 1H, H-9), 4.02 (t, J = 4.2 Hz, 1H, H-7), 3.90 (s, 3H, 10'-OMe), 3.84 (s, 3H, 11'-OMe), 2.61 (dd, J = 19.2, 2.4 Hz, 1H, H-3a), 2.17 (d, J = 19.2 Hz, 1H, H-3b); 13C NMR (150 MHz, DMSO-d6) δ: 160.8 (C-1), 157.9 (C-1'), 153.9 (C-7'), 147.7 (C-2), 143.6 (C-9'), 135.5 (C-5), 135.3 (C-8'), 126.8 (C-6), 124.0 (C-3'), 123.0 (C-5'), 120.9 (C-2'), 113.7 (C-4'), 110.1 (C-6'), 79.4 (C-9), 67.8 (C-8), 66.6 (C-7), 64.1 (C-4), 60.9 (C-11'), 56.4 (C-10'), 28.9 (C-3); HR-ESI-MS calcd for C20H20N2O9Na [M+Na] 455.1061, found 455.1057.
7-Hydroxy-2-hydroxymethyl-5-methyl-4H-chromen-4-one (5): White amorphous powder. m.p. 231.0~234.0 ℃ (lit.[30] 231.0~234.0 ℃); 1H NMR (400 MHz, DMSO-d6) δ: 6.63 (d, J = 2.4 Hz, 1H, H-8), 6.60~6.62 (m, 1H, H-6), 6.08 (t, J = 1.2 Hz, 1H, H-3), 5.69 (t, J = 6.4 Hz, 1H, 2'-OH), 4.33 (d, J = 5.2 Hz, 2H, H-2'), 2.65 (s, 3H, H-9); 13C NMR (100 MHz, DMSO-d6) δ: 178.3 (C-4), 166.8 (C-2), 161.1 (C-7), 158.9 (C-8a), 141.6 (C-5), 116.6 (C-6), 114.7 (C-4a), 108.3 (C-3), 100.6 (C-8), 59.5 (C-2'), 22.5 (C-9); HR-ESI-MS calcd for C11H9O4 [M-H] 205.0506, found 205.0500.
7-Hydroxy-2-(2-hydroxypropyl)-5-methylchromone (6):[31] White amorphous powder. m.p. 205.4~207.9 ℃; 1H NMR (400 MHz, DMSO-d6) δ: 6.62 (d, J = 2.4 Hz, 1H, H-8), 6.58~6.60 (m, 1H, H-6), 5.96 (s, 1H, H-3), 4.84 (br s, 1H, 2'-OH), 3.98~4.07 (m, 1H, H-2'), 2.65 (s, 3H, H-3'), 2.52~2.62 (m, 2H, H-1'), 1.14 (d, J = 6.4 Hz, 3H, H-9); 13C NMR (100 MHz, DMSO-d6) δ: 178.3 (C-4), 164.8 (C-2), 160.9 (C-7), 159.2 (C-8a), 141.4 (C-5), 116.5 (C-6), 114.5 (C-4a), 111.6 (C-3), 100.6 (C-8), 61.4 (C-2'), 42.9 (C-1'), 23.5 (C-3'), 22.4 (C-9). HR-ESI-MS calcd for C13H13O4 [M-H] 211.0975, found 211.0971.
Striatisporolide A (7):[32] Pale yellow amorphous solid. m.p. 116.2~117.8 ℃; 1H NMR (400 MHz, DMSO-d6) δ: 5.11~5.17 (m, 1H, H-4), 2.03 (d, J = 2.0 Hz, 3H, H-10), 1.94~2.02 (m, 1H, H-5a), 1.49~1.59 (m, 1H, H-5b), 1.20~1.31 (m, 6H, H-6, H-7, H-8), 0.85 (t, J = 6.4 Hz, 3H, H-9); 13C NMR (100 MHz, DMSO-d6) δ: 172.9 (C-1), 163.6 (C-11), 150.1 (C-3), 134.3 (C-2), 81.0 (C-4), 31.8(C-5), 30.9 (C-7), 23.8 (C-6), 21.9 (C-8), 13.8 (C-9), 10.3 (C-10); HR-ESI-MS calcd for C11H15O4 [M-H] 233.0819, found 233.0817.

4.4 ECD computation section

The TDDFT ECD calculations for compound 1 was performed with the Gaussian 09 program.[35] The conformational searching was conducted by the Spartan 14 software using the MMFF force field within an energy window of 20.9 kJ/mol. The conformers with the Boltzmann population above 5% were re-optimized at the B3LYP/631G(d) level in vacuo or M06-2X/6-311G(d,p). TDDFT ECD calculations were run at the CAM-B3LYP/TZVP or M06-2X/ TZVP level with the SMD solvent model for methanol.[36] ECD spectra were generated using the SpecDis Version 1.71 with 0.3 sigma/gamma (eV) after UV correction.[37]

4.5 Assay of anti-inflammatory activity

The anti-inflammatory activity was evaluated by determination of NO production in RAW264.7 cell culture supernatants induced by LPS with Griess reagent.[38] The RAW264.7 cells were inoculated in 96-well plates with a density of 1×105 cells per well, and treated with samples and positive control (dexamethasone) after 12 h. One hour after this treatment, the cells were exposed to 1 μg/mL LPS and cultured at 37 ℃ and 5% (ϕ) CO2 for 24 h. Next, 50 μL of culture supernatant and 100 μL of Griess reagent were mixed. The absorbance values at a wavelength of 540 nm were recorded by a microplate reader.

4.7 Assay of anti-MRSA activity

Compounds 1~7 were tested for antibacterial activities against methicillin-resistant Staphylococcus aureus ATCC- 43300, and were evaluated in 96-well plates using a modified broth microdilution method.[39]
Supporting Information HR-ESI-MS, 1D NMR, 2D NMR, IR and UV spectra of compound 1. The Supporting Information is available free of charge via the Internet at http://sioc-journal.cn.
(Zhao, C.)
[1]
Koul M.; Singh S. Anticancer Drugs 2017, 28, 11.

DOI

[2]
Li H.; Fu Y.; Song F.; Xu X. Chem. Biodiversity 2023, 20, e202301278.

[3]
de Carvalho A. C.; Ogawa C. Y.; Rodrigues L. D.; de Medeiros L. S.; Veiga T. A. M. Lymphoma 2021, 62, 2079.

[4]
Matsukuma S.; Nishizuka Y.; Watanabe J.; Okuda T. Mycoscience 1994, 35, 183.

DOI

[5]
Zheng C.-J.; Xu L.-L.; Li Y.-Y.; Han T.; Zhang Q.-Y.; Ming Q.-L.; Rahman K.; Qin L.-P. Appl. Microbiol. Biotechnol. 2013, 97, 7617.

DOI

[6]
Marinho A. M. D.; Rodrigues E.; Moitinho M. D. R.; Santos L. S. B. J. Braz. Chem. Soc. 2005, 16, 280.

DOI

[7]
Tapfuma K. I.; Sebola T. E.; Uche-Okereafor N.; Koopman J.; Hussan R.; Makatini M. M.; Mekuto L.; Mavumengwana V. Data Brief 2020, 28, 104959.

DOI

[8]
Widden P.; Parkinson A. D. Can. J. Microbiol. 1978, 24, 415.

PMID

[9]
Sun T.-T.; Yang J.-K.; Zhu H.-J.; Pan L.; Cao F. Chem. Nat. Compd. 2020, 56, 968.

DOI

[10]
Cui H.; Li X.-D.; Li M.-Q.; Lu F.-M.; Wang Y.-H.; Liu D.; Kang J.-G. Chin. J. Mar. Drugs 2017, 36, 41.

[11]
Smetanina O. F.; Kalinovsky A. I.; Khudyakova Y. V.; Pivkin M. V.; Dmitrenok P. S.; Fedorov S. N.; Ji H.; Kwak J. Y.; Kuznetsova T. A. J. Nat. Prod. 2007, 70, 906.

PMID

[12]
Yang L.-J.; Lv L.; Han Z.; Gu Y.-C.; Li X.; Shao C.-L.; Liu Z.-Q.; Wang C.-Y. Chin. J. Chem. 2025, 43, 268.

DOI

[13]
Zeng F.-R.; Chen C.-M.; Al Chnani A. A.; Zhou Q.; Tong Q.-Y.; Wang W.-J.; Zang Y.; Gong J.-J.; Wu Z.-D.; Liu J.-J.; Wang J.-P.; Zhu H.-C.; Zhang Y.-H. Bioorg. Chem. 2019, 86, 176.

DOI

[14]
Zhu M.-L.; Zhang X.-M.; Feng H.-M.; Dai J.-J.; Li J.; Che Q.; Gu Q.-Q.; Zhu T.-J.; Li D.-H. J. Nat. Prod. 2017, 80, 71.

DOI

[15]
Wang W.-J.; Liao L.-X.; Huang Z.-D.; Wei F.-T.; Yang X.-L. ACS Omega 2022, 7, 35280.

DOI

[16]
Ye X.; Anjum K.; Song T.; Wang W.; Yu S.; Huang H.; Lian X.-Y.; Zhang Z. Nat. Prod. Res. 2015, 30, 1156.

DOI

[17]
Aoki Y.; Yamazaki T.; Kondoh M.; Sudoh Y.; Nakayama N.; Sekine Y.; Shimada H.; Arisawa M. J. Antibiot. 1992, 45, 160.

PMID

[18]
Wang H.; Li Y.-J.; Wang Y.-F.; Shi T.; Wang B. Fermentation 2024, 10, 157.

DOI

[19]
Qiao S.-J.; Zhai L.; Huang S.-H.; Hong R. J. Fujian Normal Univ. (Nat. Sci. Ed.) 2020, 36, 1 (in Chinese).

(乔思捷, 翟丽, 黄莎华, 洪然, 福建师范大学学报(自然科学版), 2020, 36, 1.)

[20]
Yan L.-H.; Li X.; Wang B.-G. Nat. Prod. Rep. 2023, 40, 1874.

DOI PMID

[21]
Liu J.-Y.; Jiang Y.-Y.; Li P.-J.; Yao B.; Song Y.-J.; Gao J.-X.; Said G.; Gao Y.; Lai J.-Y.; Shao C.-L. Mar. Life Sci. Technol. 2024, 6, 502.

DOI

[22]
Liao H.-X.; Zheng C.-J.; Huang G.-L.; Mei R.-Q.; Nong X.-H.; Shao T.-M.; Chen G.-Y.; Wang C.-Y. J. Nat. Prod. 2019, 82, 2211.

DOI

[23]
Wang B.; Zeng W.-N.; Li G.-Y.; Xiao M.; Wei F.-F.; Luo Y.-P.; Niu Z.-G.; Huang G.-L.; Zheng C.-J. Chin. J. Org. Chem. 2023, 43, 332 (in Chinese).

DOI

(王斌, 曾尾女, 李杲钰, 肖媚, 韦方芳, 罗由萍, 钮智刚, 黄国雷, 郑彩娟, 有机化学, 2023, 43, 332.)

DOI

[24]
Bai M.; Huang G.-L.; Mei R.-Q.; Wang B.; Luo Y.-P.; Nong X.-H.; Chen G.-Y.; Zheng C.-J. Mar. Drugs 2019, 17, 433.

DOI

[25]
Bai M.; Zheng C.-J.; Chen G.-Y. J. Nat. Prod. 2021, 84, 2104.

DOI

[26]
Bai M.; Zheng C.-J.; Huang G.-L.; Mei R.-Q.; Wang B.; Luo Y.-P.; Zheng C.; Niu Z.-G.; Chen G.-Y. J. Nat. Prod. 2019, 82, 1155.

DOI

[27]
Zeng W.-N.; Cai J.; Wang B.; Chen L.-Y.; Pan C.-X.; Chen S.-J.; Huang G.-L.; Zheng C.-J. J. Asian Nat. Prod. Res. 2022, 24, 679.

DOI

[28]
Garo E.; Starks C. M.; Jensen P. R.; Fenical W.; Lobkovsky E.; Clardy J. J. Nat. Prod. 2003, 66, 423.

DOI

[29]
Zhu M.-L.; Yang Z., Feng H.-M.; Gan Q.; Che Q.; Zhu T.-J.; Gu Q.-Q.; Han B.-N.; Li D.-H. RSC Adv. 2017, 7, 48019.

DOI

[30]
Kimura Y.; Shiojima K.; Nakajima H.; Hamasaki T. Biosci., Biotechnol., Biochem. 1992, 56, 1138.

[31]
Huang H.; Cao Y.; Tian L.; Lin W.; Zhang K. Chem. Nat. Compd. 2014, 50, 402.

DOI

[32]
Stewart M.; Capon R. J.; Lacey E.; Tennant S.; Gill J. H. J. Nat. Prod. 2005, 68, 581.

DOI

[33]
Jans P. E.; Mfuh A. M.; Arman H. D.; Shaffer C. V.; Larionov O. V.; Mooberry S. L. J. Nat. Prod. 2017, 80, 676.

DOI

[34]
Sirimangkalakitti N.; Lin J.-Y.; Harada K.; Setiawan A.; Arisawa M.; Arai M. Molecules 2024, 29, 2048.

DOI

[35]
Frisch M. J.; Trucks G. W.; Schlegel H. B.; Scuseria G. E.; Robb M. A.; Cheeseman J. R.; Scalmani G.; Barone V.; Mennucci B.; Petersson G. A.; Nakatsuji H.; Caricato M.; Li X.; Hratchian H. P.; Izmaylov A. F.; Bloino J.; Zheng G.; Sonnenberg J. L.; Hada M.; Ehara M.; Toyota K.; Fukuda R.; Hasegawa J.; Ishida M.; Nakajima T.; Honda Y.; Kitao O.; Nakai H.; Vreven T.; Montgomery Jr., J.A.; Peralta J. E.; Ogliaro F.; Bearpark M.; Heyd J. J.; Brothers E.; Kudin K. N.; Staroverov V. N.; Keith T.; Kobayashi R.; Normand J.; Raghavachari K.; Rendell A.; Burant J. C.; Iyengar S. S.; Tomasi J.; Cossi M.; Rega N.; Millam N. J.; Klene M.; Knox J. E.; Cross J. B.; Bakken V.; Adamo C.; Jaramillo J.; Gomperts R.; Stratmann R. E.; Yazyev O.; Austin A. J.; Cammi R.; Pomelli C.; Ochterski J. W.; Martin R. L.; Morokuma K.; Zakrzewski V. G.; Voth G. A.; Salvador P.; Dannenberg J. J.; Dapprich S.; Daniels A. D.; Farkas Ö.; Foresman J. B.; Ortiz J. V.; Cioslowski J.; Fox D. J. Gaussian 09, Gaussian, Inc., Wallingford CT, 2013.

[36]
Pescitelli G.; Bruhn T. Chirality 2016, 28, 466.

DOI PMID

[37]
Bruhn T.; Schaumloffel A.; Hemberger Y.; Bringmann G. Chirality 2013, 25, 243.

DOI

[38]
Dirsch V.; Stuppner H.; Vollmar, A. Planta Med. 1998, 64, 423.

[39]
Wang J.-F.; Cong Z.-W.; Huang X.-L.; Hou C.-X.; Chen W.-H.; Tu Z.-C.; Huang D.-Y.; Liu Y.-H. Org. Lett. 2018, 20, 1371.

DOI

文章导航

/